Abametapir and Olanzapine: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jun 30, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Abametapir
No brand names on recordOlanzapine
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Abametapir is a lotion used to treat head lice. Even though you rub it on your scalp, a little can get into your body and briefly block a liver enzyme called CYP1A2. That enzyme is one of the main ways your body breaks down olanzapine, a medicine used for mood and mental health conditions.
When that enzyme is slowed down, olanzapine can build up higher than usual. That could mean more drowsiness, dizziness, or other side effects. The good news is this is easy to plan around. Talk with your pharmacist or doctor before using the lice treatment so your care team can guide the timing and keep you safe.
Mechanism: Abametapir inhibits CYP1A2. Olanzapine is a CYP1A2 substrate (neither drug is a prodrug), so inhibition reduces its clearance and increases exposure (AUC/Cmax).
Direction: Increased olanzapine effect and adverse-event risk (sedation, orthostasis, anticholinergic/metabolic effects).
Evidence: Theoretical; magnitude and onset not well characterized. Rated major.
- Per labeling, avoid CYP1A2 substrates for 2 weeks after a single abametapir application.
- If concomitant use is unavoidable, avoid abametapir.
- If exposure occurs, monitor for enhanced olanzapine effects; dose may need individualized adjustment.
What happens
Increased exposure of CYP1A2 substrates
Interaction Deep Dive
Refrain from administering CYP1A2 substrates during the 2 weeks following abametapir application. When avoidance is not practical, do not use abametapir1.
Why it happens (mechanism)
Inhibition of CYP1A2-mediated metabolism by abametapir
How to manage this interaction
This is generally handled by timing and planning, since abametapir is usually a single-application lice treatment.
- Keep taking your olanzapine as prescribed. Do not stop or change it on your own.
- Before using abametapir, tell your pharmacist or prescriber that you take olanzapine.
- The guidance on file is to avoid CYP1A2 substrates for 2 weeks after applying abametapir; if that is not feasible, the abametapir may be avoided instead. Your care team can decide which fits you.
- If both are used, your team may monitor you more closely for extra drowsiness or dizziness.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Abametapir and Olanzapine together?
Abametapir can raise olanzapine levels by blocking the enzyme that clears it, so let your pharmacist or doctor plan the timing before you use the lice treatment. Standard guidance is to avoid this olanzapine (a CYP1A2 substrate) for 2 weeks after applying abametapir. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Abametapir and Olanzapine interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Abametapir and Olanzapine interaction managed?
This is generally handled by timing and planning, since abametapir is usually a single-application lice treatment. Keep taking your olanzapine as prescribed. Do not stop or change it on your own. Before using abametapir, tell your pharmacist or prescriber that you take olanzapine. The guidance on file is to avoid CYP1A2 substrates for 2 weeks after applying abametapir; if that is not feasible, the… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Abametapir or Olanzapine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: XEGLYZE(TM) topical lotion, abametapir topical lotion. Dr Reddy’s Laboratories Inc (per FDA), Princeton, NJ, 2020. DailyMed
Keep reading about Abametapir
Keep reading about Olanzapine
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist